🔎 Trials Near Me

Home › Castration-Resistant Prostatic Cancer › New York › New York City

Pag-aaral pangklinika para sa Castration-Resistant Prostatic Cancer sa New York City, NY

Isang pag-aaral para sa Castration-Resistant Prostatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New York City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Nagre-recruitPhase 3
  • NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
  • Columbia University Medical Center, New York
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT07164443

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Nagre-recruitPhase 3
  • NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07225946

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Nagre-recruitPhase 1/2
  • Memorial Sloan Kettering Cancer Center ( Site 0006), New York
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06863272

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Nagre-recruitPhase 1
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medicine, New York
Edad 18 hanggang 100 · Kalalakihan · Na-update Ago 13, 2026 · NCT05519449

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Nagre-recruitPhase 1
  • Memorial Sloan Kettering Cancer Center, New York
Edad 18 pataas · Kalalakihan · Na-update Ago 10, 2026 · NCT06067841

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Nagre-recruitPhase 1/2
  • Weill Cornell Medicine at New York-Presbyterian, New York
Edad 18 pataas · Kalalakihan · Na-update May 6, 2026 · NCT04868604

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Nagre-recruitPhase 1
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Edad 18 pataas · Kalalakihan · Na-update Nob 21, 2025 · NCT05743621

Pag-aaral para sa Castration-Resistant Prostatic Cancer sa ibang lungsod

Iba pang pag-aaral sa New York City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.